Nexien BioPharma Inc (NXEN)

[FELLER]

Check out this Tweet as well

$NXEN had mentioned the #FDA pathway for Myotonic Dystrophies and Myotonia in the 10-K, saying it "may fall under the Orphan Drug Act of 1983".

That's the next PR I'm hoping to hear about in relation to Dr. Schoser's area of research. :)#MJOTCS #CannabisStocks #MarijuanaStocks pic.twitter.com/NyUI1XlwyM

— OwnTheFloat.com (@OwnTheFloat) November 6, 2018

I hope more people start Retweeting these types of things to start building up an interested audience. :)